Skip Navigation
 
 
 
 xxx
JHU NIMH photo banner
 
Print This Page
Share this page: More
 

The NIMH Center for Novel Therapeutics of HIV-associated Cognitive Disorders

The Johns Hopkins National Institute of Mental Health (NIMH) Center for Novel Therapeutics of HIV-associated Cognitive Disorders is funded by NIMH Grant # P30MH075673.

The Johns Hopkins NIMH Center is comprised of an interdisciplinary research team who has pooled their talents to study the nature of HIV-associated neurocognitive disorders (HAND). Their aim is to translate discoveries of the pathophysiological mechanisms into novel therapeutics for HAND.

Objectives

  • To integrate aspects of ongoing research in HAND and SIV encephalitis
     
  • Develop high-throughput and screening assays for identifying novel therapeutic compounds
     
  • Use proteomics and lipidomics approaches to indentifying surrogate markers of disease activity
     
  • Disseminate information and education about HAND through existing and new educational systems, including the JHU AIDS Education Training Center and the JHU Center for Global Clinical Education
     
  • Facilitate the entry of new investigators into Neuro-AIDS research, and to catalyze new areas of research, particularly where relevant for drug discovery or the development of validated surrogate markers
group photo of NIMH faculty
 

The Johns Hopkins NIMH Center newsletter

Clinical Perspectives

HANSA 2011 Presentations

View a presentation by Dr Justin McArthur entitled "NeuroAIDS Research Needs in the Era of HAART."
Learn more.

Out-of-State and International Patients - Find Out More

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.